Patent holdings for IPC class C07C 309/30

Total number of patents in this class: 264

10-year publication summary

30
25
22
30
26
30
31
12
16
2
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Intra-Cellular Therapies, Inc.
393
10
Journey Medical Corporation
93
7
Merck Sharp & Dohme LLC
3751
7
BASF SE
20432
5
ChemoCentryx, Inc.
393
5
Gilead Sciences, Inc.
1951
5
Imago Biosciences, Inc.
37
5
Shionogi & Co., Ltd.
889
5
WisTa Laboratories Ltd.
125
5
Shin-Etsu Chemical Co., Ltd.
5446
4
Advansix Resins & Chemicals LLC
280
4
Apotex Inc.
206
4
Pharmatrophix, Inc.
22
4
Purdue Pharma L.P.
512
4
Teva Pharmaceuticals International GmbH
382
4
Eidos Therapeutics, Inc.
15
4
Evonik Oxeno GmbH & Co. KG
304
4
Bristol-myers Squibb Company
4863
3
Merck Patent GmbH
5842
3
Uop LLC
4188
3
Other owners 169